Skip to search.
 TSX Down 0.62% TSX Ventures Down 0.53%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
27.19 Up 1.34(5.18%) May 2, 4:00PM EDT
Prev Close:25.85
Open:25.86
Bid:24.50 x 200
Ask:27.88 x 100
1y Target Est:41.33
Beta:1.13489
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:25.42 - 27.22
52wk Range:24.83 - 43.63
Volume:709,070
Avg Vol (3m):849,611
Market Cap:1.24B
P/E (ttm):108.76
EPS (ttm):0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ACORUp 5.18%1.24B
BIIBDown 0.47%59.95B

Key Statistics

Forward P/E (1 yr):28.32
P/S (ttm):2.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.73
Quarterly EPS Est (Jun-16) :0.20
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):1.28

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback